VF
RNTX

Virtu Financial’s Rein Therapeutics RNTX Stock Holding History

Virtu Financial’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,663
Closed -$16K – 2479
2025
Q4 		$16K Buy
+13,663
New +$18.8K ﹤0.01% 1463
2022
Q3 		– Sell
-1,030
Closed -$5K – 2326
2022
Q2 		$5K Sell
1,030
-37
-3% -$340 ﹤0.01% 1466
2022
Q1 		$11K Buy
+1,067
New +$9.66K ﹤0.01% 1356
2021
Q4 		– Sell
-9,047
Closed -$185K – 2266
2021
Q3 		$185K Buy
+9,047
New +$198K 0.02% 944
2021
Q2 		– Sell
-7,317
Closed -$209K – 2163
2021
Q1 		$209K Buy
7,317
+6,453
+747% +$221K 0.01% 1063
2020
Q4 		$18K Buy
864
+239
+38% +$5.97K ﹤0.01% 1364
2020
Q3 		$16K Sell
625
-540
-46% -$12.7K ﹤0.01% 938
2020
Q2 		$28K Buy
+1,165
New +$19K ﹤0.01% 1097
2019
Q4 		– Sell
-3,347
Closed -$45K – 1933
2019
Q3 		$45K Buy
3,347
+2,212
+195% +$30.6K ﹤0.01% 1212
2019
Q2 		$16K Buy
+1,135
New +$29.8K ﹤0.01% 1364

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Virtu Financial's RNTX Position: Q1 2026 in Review

Virtu Financial sold out of Rein Therapeutics (RNTX) in Q1 2026, closing a stake of 13,663 shares — an estimated $16K sold.

Virtu Financial first reported a position in RNTX in Q2 2019 and held it in 10 quarters. The position peaked at $209K in Q1 2021. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Virtu Financial reported no remaining Rein Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 13,663 Rein Therapeutics shares in Q1 2026, an estimated $16K.
  • Virtu Financial first reported a position in Rein Therapeutics in Q2 2019 and held it in 10 quarters.
  • Virtu Financial's Rein Therapeutics position peaked at $209K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.